Correlation Between Handa Pharmaceuticals and Asia Vital

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Asia Vital at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Asia Vital into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Handa Pharmaceuticals and Asia Vital Components, you can compare the effects of market volatilities on Handa Pharmaceuticals and Asia Vital and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Asia Vital. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Asia Vital.

Diversification Opportunities for Handa Pharmaceuticals and Asia Vital

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Handa and Asia is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Asia Vital Components in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Asia Vital Components and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Asia Vital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Asia Vital Components has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Asia Vital go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and Asia Vital

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to under-perform the Asia Vital. But the stock apears to be less risky and, when comparing its historical volatility, Handa Pharmaceuticals is 1.36 times less risky than Asia Vital. The stock trades about -0.53 of its potential returns per unit of risk. The Asia Vital Components is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  62,600  in Asia Vital Components on August 30, 2024 and sell it today you would earn a total of  400.00  from holding Asia Vital Components or generate 0.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Handa Pharmaceuticals  vs.  Asia Vital Components

 Performance 
       Timeline  
Handa Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Handa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Asia Vital Components 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Asia Vital Components are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Asia Vital may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Handa Pharmaceuticals and Asia Vital Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Handa Pharmaceuticals and Asia Vital

The main advantage of trading using opposite Handa Pharmaceuticals and Asia Vital positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Asia Vital can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Asia Vital will offset losses from the drop in Asia Vital's long position.
The idea behind Handa Pharmaceuticals and Asia Vital Components pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios